ArticleMethods in molecular biology (Clifton, N.J.)2026
Method for Selection of Antithrombin Disulfide-Bonded Subsets.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies of coagulation proteins have demonstrated that they are frequently produced in multiple partially disulfide-bonded states, with each state potentially influencing the protein's function. The ability to isolate distinct disulfide-bonded forms could be valuable for functionally characterizing these protein subsets. Here, we describe protocols for the selection of a disulfide-bonded subset of antithrombin, characterized by its distinct biophysical properties, using a limiting quantity of heparin-Sepharose. Antithrombin is a key anticoagulant protein that regulates the proteolytic activity of several procoagulant proteases, and its deficiency is associated with pathological thrombosis. Antithrombin contains three disulfide bonds, which exist in both formed and unformed states in human plasma, demonstrating that antithrombin circulates in blood in multiple disulfide-bonded states. This method provides a practical approach for isolating and studying partially disulfide-bonded subsets of antithrombin and can be extended to other disulfide-bonded protein states.
Indexed as
Identifiers
42681367What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.